Medscape Hematology-Oncology Headlines This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Pancreatic Cystic Neoplasms Rarely Turn Cancerous Pancreatic Cystic Neoplasms Rarely Turn Cancerous
Individuals with intraductal papillary mucinous neoplasms that lack ' worrisome or high-risk features ' have no greater risk of pancreatic cancer than individuals without IPMNs.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 30, 2023 Category: Cancer & Oncology Tags: Gastroenterology News Source Type: news
New Column: Practical AI With Arturo Loaiza-Bonilla New Column: Practical AI With Arturo Loaiza-Bonilla
An expert on artificial intelligence and precision medicine in cancer care introduces his new column.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 30, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news
Avoid Anti-HER2 Cancer Therapies During Pregnancy Avoid Anti-HER2 Cancer Therapies During Pregnancy
Women with HER2-positive breast cancer who receive HER2-targeted therapies during pregnancy face a higher risk for severe adverse outcomes to their fetus or newborn, new research indicates.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 29, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
FDA Investigates Secondary Cancers From CAR T-Cell Therapies FDA Investigates Secondary Cancers From CAR T-Cell Therapies
The FDA has determined that the risk for lymphoma and other T-cell cancers may apply to approved BCMA- and CD-19 –directed CAR T-cell immunotherapies.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 28, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news
FDA OKs New Agent to Block Chemotherapy-Induced Neutropenia FDA OKs New Agent to Block Chemotherapy-Induced Neutropenia
The new colony-stimulating factor from China proved comparable to pegfilgrastim (Neulasta) in clinical testing.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 28, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news